ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly scope 2 location-based GHG emissions (metric tonnes CO2e) [reported through FY2022]
Lilly 2022 ESG Report
Latest, FY2022
415,000
Period ended Dec 31, 2022
Change on a year earlier
-15.0%
488,000 in FY2021
History
4 years
Since FY2019
Sources
1
Lilly 2022 ESG Report
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 2 location-based GHG emissions (metric tonnes CO2e) [reported through FY2022] | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 415,000 | -15.0% | Lilly 2022 ESG Report ↗ |
| FY2021 | Dec 31, 2021 | 488,000 | -11.4% | Lilly 2022 ESG Report ↗ |
| FY2020 | Dec 31, 2020 | 551,000 | -7.6% | Lilly 2022 ESG Report ↗ |
| FY2019 | Dec 31, 2019 | 596,000 | – | Lilly 2022 ESG Report ↗ |
Cite this data
StockData. (2026). Eli Lilly Scope 2 location-based GHG emissions (metric tonnes CO2e) [reported through FY2022], annual FY2019–FY2022 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/esg_scope2_loc_legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.